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Abstract
Purpose The aim was to investigate desire for children, diffi-
culties achieving a pregnancy, and infertility distress among
survivors 3 to 7 years after cancer treatment in reproductive
age.
Methods Cancer survivors were identified in national
population-based cancer registries. Eligible subjects presented
with selected cancer diagnoses between 2003 and 2007 be-
tween the ages of 18 to 45. A postal questionnaire including
study-specific questions, the Short-Form 36 Health Survey
and the Fertility Problem Inventory, was sent to 810 survivors,
and 484 participated (60 % response).
Results Most survivors who had a pretreatment desire for
children still wanted children 3–7 years after treatment, and
this group was characterized by young age and being childless
at diagnosis. In addition, a substantial group of survivors (n=
55, 17 %) that did not have a pretreatment desire for children
had changed their mind about wanting children after treat-
ment. About a third of the survivors with a desire to have
children had experienced difficulties achieving a pregnancy
after the cancer treatment, and an unfulfilled desire to have
children was associated with worse mental health. Survivors
presently facing difficulties achieving a pregnancy reported
moderate levels of infertility distress and expressed low inter-
est in using gamete donation.
Conclusions Health professionals in cancer care need to be
aware that patients’ plans for future children may change,
particularly if they are young and childless. All patients of
reproductive age should be provided with adequate informa-
tion about the impact of cancer treatment on future fertility and
fertility preservation.
Keywords Cancer .Care .Qualityof life .Attitudes .Fertility
distress . Infertility
Background
The desire for biological children is generally strong, and
infertility is a known cause of psychological distress with a
negative impact on quality of life (QoL) [1]. Progress in
cancer therapy has increased survival rates, and the number
of men and women living with a history of cancer is steadily
rising [2]. With this development, a growing group of cancer
survivors will reach an age where they want to start a family.
However, certain cancer treatments may have an adverse
impact on reproductive health for both males and females
and result in impaired sperm production and permanent loss
of oocytes and premature menopause, respectively [3]. The
overall probability of parenthood in cancer survivors may be
reduced by up to 50%, as found when comparing with sibling
controls [4].
A number of methods can be performed to preserve young
cancer patients’ future ability to have children. For men,
sperm banking is a simple and effective method that has been
used for several decades [5]. For women, fertility preservation
(FP) is more demanding and time consuming, as egg retrieval
requires invasive methods and often hormone stimulation [5].
When there is no time for suchmethods, ovarian tissuemay be
retrieved in order to preserve cortical tissue and primordial
follicles [6]. As the feasibility of FP is higher for men than for
women, FP is practiced by a larger proportion of male cancer
patients compared to females (60 vs. 2–4 %) [7, 8], and a low
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percentage of female cancer patients are being referred to
fertility clinics [9].
Specific guidelines and decision aids have been developed
to improve young cancer patients’ access to information on FP
options, with particular emphasis on the need for providing
timely information to female patients, as some FP methods
may require a period of up to 2–3 weeks to accomplish
[10–13]. Physicians are encouraged to initiate a discussion
on cancer treatment impact on reproductive ability prior to
treatment start and to provide information about FP to all
patients, regardless of whether they already have children or
not [12].
It has been shown that patients who had a desire to have
children at the time of cancer treatment are more likely to
receive fertility-related information [7] and to be referred to a
fertility clinic for FP [14]. However, since qualitative studies
with young adult cancer survivors indicate that patients may
change their mind regarding future children [15, 16], there is a
risk that some patients who decline FP because they do not
desire children at the time of their treatment may regret their
decision later.
Cancer survivors unable to conceive after treatment have
reported lower physical well-being and QoL compared to
survivors who have had children after cancer treatment [17,
18]. In addition, cancer survivors who have become infertile
report a strain in intimate relationships, being rejected by
partners, and difficulties beginning new relationships [19].
Even when there is no confirmed infertility, many survivors
express fertility-related distress, including worry regarding
premature menopause and fear of future infertility [20, 21].
Cancer survivors who experience infertility can use their
cryopreserved sperm, oocytes, or embryos to conceive. They
can also choose to use gamete donation or to adopt, although
adoption agencies may consider a cancer experience as a
contraindication to adopting [22]. However, there is limited
knowledge about cancer survivors’ perceptions of, and pref-
erences for, alternative parenthood options [23].
Previous findings by our group [7] indicate marked sex
differences in fertility-related information and use of fer-
tility preservation among young adult cancer patients. Fur-
thermore, we found that patients with a desire to have
children were more likely to receive fertility-related infor-
mation. Based on these findings, the aim of the present
study was to investigate reproductive desire among survi-
vors 3 to 7 years after cancer treatment in reproductive age.
The following research questions were addressed: (1) Is
desire for children among survivors related to their repro-
ductive desire at diagnosis and sociodemographic charac-
teristics? (2) Is fulfillment of a desire for children related to
indicators of mental health among survivors? (3) To what
extent do survivors with difficulties achieving a pregnancy




The sample was identified from the Swedish Cancer Registry
and selected Quality Cancer Registries, which are population-
based registers administered by the Regional Cancer Center
(RCC) Uppsala Örebro, and vital status was verified in the
National Population Register. The sample consisted of female
and male cancer survivors who met the following inclusion
criteria: age 18–45 at time of a diagnosis of lymphoma
(Hodgkin and non-Hodgkin), acute leukemia (acute lymphatic
leukemia and acute myeloid leukemia), testicular cancer, ovar-
ian cancer, or breast cancer treated with chemotherapy. The
sample included patients diagnosed from 2003 to 2007 in the
Uppsala Örebro health-care region (around two million inhab-
itants). These diagnoses were selected as they involved treat-
ments requiring gonadotoxic chemotherapy and/or treatment
directed at the reproductive organs. A total of 494 women and
316 men met the inclusion criteria and were sent a postal
questionnaire in 2010. A maximum of two reminders were
sent to nonresponders. Returning a completed questionnaire
was considered as giving informed consent. The study was
approved by the Regional Ethical Review Board in Stock-
holm, Sweden (no. 2010/195-31/4).
Measures
Data were obtained using a survey including validated instru-
ments measuring mental health and infertility-related stress as
well as study-specific items developed in collaboration with
experts in oncology, reproduction, psychology, and cancer
care. The face validity and feasibility of the study-specific
items were confirmed in a pilot study including a subsample
of 66 cancer survivors from the present study.
Mental health
Mental health was measured by the Mental Component Sum-
mary (MCS) scale of the Swedish version of the Short-Form
36 Health Survey (SF-36), reported to have high validity and
reliability [24, 25]. Based on the eight scales included in the
SF-36, two summary scales can be constructed for physical
(physical component summary, PCS) and mental health (men-
tal component summary, MCS) [26]. The PCS is primarily a
measure of physical function, role function, bodily pain, and
general health, whereas theMCSmainly encompasses vitality,
social function, and mental health [27].
Infertility-related stress
The Fertility Problem Inventory (FPI) [28] was used to assess
infert i l i ty-related stress within two dimensions:
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representations about the importance of parenthood (FPI-
dimension RIP) and impact on life domains (FPI-dimension
ILD) [29]. The instrument comprises 46 items organized in
five subscales and has been shown to have high validity and
reliability among patients undergoing infertility treatment
[30]. The two subscales need for parenthood and rejection
of a childfree lifestyle form the main dimension FPI-
dimension RIP. The three subscales sexual concern, social
concern, and relationship concern form the main dimension
FPI-dimension ILD. The FPI also has a total summary score,
global stress, based on the scoring in all five subscales. The
responses are given on a 6-grade Likert scale (1 = strongly
agree, 6 = strongly disagree); as the FPI was originally devel-
oped for patients undergoing infertility treatment, a seventh
response alternative was added for the present study, “Not
applicable”. All participants in the present study were asked to
answer the questions in the FPI-dimension RIP, and the sur-
vivors who reported presently facing difficulties achieving a
pregnancy were asked to additionally answer the questions in
the FPI-dimension ILD. The FPI was translated into Swedish
for this study using independent forward and backward trans-
lations by professional translators with Swedish and English,
respectively, as their first language.
Behavioral intentions in case of infertility
Behavioral intentions in case of infertility were assessed by
three items adapted from earlier research [31]. Participants
were requested to indicate the likelihood of undergoing
in vitro fertilization (IVF), using donor oocytes or sperm,
and adopting in case of infertility. The VAS scales had the
endpoints “Entirely unlikely” (0 mm) and “Highly likely”
(100 mm).
Sociodemographic and reproductive variables
Sociodemographic and clinical variables included age, sex,
diagnosis, level of education, and marital status. Reproductive
variables included children at the time of diagnosis, children
born after cancer treatment, pretreatment desire for
(additional) children, and desire for children at time of study,
as well as posttreatment and present difficulties achieving a
pregnancy. In addition, the frequency of using FP was
assessed by study-specific questions, as has previously been
reported for the present sample [7].
Statistical methods
Differences in the distributions of categorical variables were
assessed by using chi-square tests and differences in continu-
ous variables by t test or ANOVA (post hoc Games-Howell as
assumption of normal distribution was violated). For the anal-
yses of present difficulties achieving a pregnancy, only
women aged ≤40 were included in the analyses. Statistical
analyses were performed using SPSS (IBM SPSS Statistics




Out of the 810 eligible cancer survivors 3–7 years post-
diagnosis, seven had no known address. Of 803 survivors
who were contacted, 484 completed the survey (156 men
and 328 women), yielding a 60 % response rate. A compari-
son between responders and nonresponders showed that a
higher percentage of women participated compared to men
(67 vs. 50 %, χ2=22.977, df=1, p<0.001), but no differences
were found with regard to age at diagnosis, age at the time of
study, or time since diagnosis. Differences regarding
sociodemographic and reproductive characteristics between
male and female participants are presented in Table 1.
Desire for children before cancer treatment and 3–7 years
post-diagnosis
Individuals with a desire for children before treatment
Among participants who reported a pretreatment desire for
children (71 men and 81 women), there were significant
differences in age and parenthood status between those whose
desire for children remained persistent 3–7 years post-
diagnosis and those who reported a change in desire (Table 2).
Being older and already having children at the time of diag-
nosis characterized those survivors who changed their mind
and no longer had a desire to have children when 3 to 7 years
had passed. In addition, 16 individuals in this group had
children between the cancer diagnosis and the time of the
study and had subsequently fulfilled their desire to have
children.
About half of those with a pretreatment desire for children
reported a definite desire for children 3–7 years later; this
group was characterized by younger age and lower frequency
of children than the remaining groups.
Individuals with no desire for children before treatment
Among participants who reported having no pretreatment
desire for children (83 men and 246 women), there were
significant differences between those who kept this standpoint
3–7 years post-diagnosis and those who reported a change in
desire (Table 2). Being older, female, and already having
children at the time of diagnosis characterized those survivors
who continued to feel no desire for (additional) children. One
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of six survivors reported that their desire had changed from no
pretreatment desire for children to a definite or possible desire
to have children 3–7 years later. These groups were charac-
terized by younger age and lower percentage of children at
diagnosis. The reported use of FP was relatively frequent
among the men who had changed their standpoint to a definite
(90 %) or possible desire for children (53 %), while none of
the women in these groups had performed any FP.
Table 1 Sociodemographic and clinical characteristics of participants
Characteristics Men (n=156) Women (n=328) p
Age at time of study, mean (SD) 37.8 (7.2) 42.8 (6.9) <0.00a
Time since diagnosis, mean (SD) 4.9 (1.4) 5.0 (1.4) NS
Diagnosis, no. (%)
Breast cancer – 245 (74.7) –
Ovarian cancer – 17 (5.2) –
Lymphoma 35 (22.4) 50 (15.2) NS
Leukemia 10 (6.4) 16 (4.9) NS
Testicular cancer 111 (71.2) – –
Marital status at time of study, no. (%) NS
Living alone 31 (19.9) 64 (19.5)
Married/cohabiting 125 (80.1) 264 (80.5)
Educational level at time of studyb, no. (%) NS
No university education 105 (67.3) 197 (60.4)
University education 51 (32.7) 129 (39.6)
Children at time of study, no. (%) 97 (62.2) 272 (82.9) <0.001c
Children born after diagnosis, no. (%) 36 (23.0) 24 (7.3) <0.001c
Desire for children at time of study, no. (%) 52 (33.3) 43 (13.1) <0.001c
Posttreatment difficulties achieving a pregnancy, no. (%) 32 (20.5) 36 (11.0) 0.007c
Current difficulties achieving a pregnancy, no. (%) 23 (14.7) 30 (9.1) NS
a Between sex, two-tailed t test
b Two women did not answer the question
c Between sex, two-tailed χ2 test
Table 2 Desire for children 3–7 years post-diagnosis among survivors in relation to pretreatment desire for children and demographic factors



















Age at study (mean, SD) 33.4 (6.7) 37.2 (4.8) 39.7 (4.5) <0.001a 30.7 (6.3) 36.9 (7.5) 45.4 (4.4) <0.001b
Sex, no. (%) NS <0.001c
Women 35 (45.5) 24 (58.5) 22 (64.7) 8 (44.4) 18 (48.6) 220 (80.3)
Men 42 (54.5) 17 (41.5) 12 (35.3) 10 (55.6) 19 (51.4) 54 (19.7)
Children, no. (%)
At diagnosis 16 (20.8) 18 (43.9) 26 (76.5) <0.001d 1 (5.6) 24 (64.9) 251 (91.6) <0.001d
Born after diagnosis 15 (19.5) 19 (43.3) 16 (47.1) 0.002e 0 (-) 1 (2.7) 8 (2.9) NS
aANOVA, post hoc Games-Howell, significant difference between “definite desire” and “possible desire,” and between “definite desire” and “no desire”
b ANOVA, post hoc Games-Howell, significant difference between all groups
c Chi-square test, significant difference between definite desire and no desire, and between possible desire and no desire
d Chi-square test, significant difference between all groups
e Chi-square test, significant difference between definite desire and no desire, and between definite desire and possible desire
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Mental health in relation to fulfillment of a pretreatment
desire for children
Among survivors with a pretreatment desire to have children,
those who had had children after the cancer treatment rated
their mental health (SF-36 MCS) as better (n=49, M=47.76)
compared to those who had not had any children (n=98, M=
43.03) [t(145)=2.28, p=0.024].
Difficulties achieving a pregnancy, infertility distress,
and behavioral intentions
At the time of the study, 83 survivors (51 men aged 24–43 and
32 women aged 22–39) reported a desire to have children. Of
these, about half had not tried to conceive (n=46), and 13 %
(n=11) had not experienced any difficulties achieving a preg-
nancy. One in three survivors (n=26) reported having experi-
enced difficulties conceiving after cancer treatment, and 19 of
these reported that they presently experienced such
difficulties.
The 19 survivors who presently faced difficulties achieving
a pregnancy (12 men and 7 women) represented 22.3 % of the
survivors with a desire to have children at time of study. The
mean age was 33 years (men, 24–42; women, 23–38), all but
one womanwas married or cohabiting, and 42% had previous
children (4 men and 4 women). Of the 12 men, 9 had cryo-
preserved sperm, and none of the women had undergone any
FP. The level of infertility distress in the subgroup is presented
in Table 3. The survivors’ behavioral intentions in case of
infertility are presented in Fig. 1
Discussion
The present results show that, among cancer survivors who
reported a pretreatment desire for children, one third had
succeeded in having children, and a majority wanted
(additional) children 3–7 years post-diagnosis. Interestingly,
one out of six of the survivors who reported no pretreatment
desire for children had subsequently changed their mind about
wanting children. Not fulfilling a desire for children was
associated with worse mental health compared to fulfilling
the desire. Survivors with difficulties achieving a pregnancy
reported moderate levels of infertility distress and low interest
in using gamete donation treatment.
Our results indicate that the desire to have children among
cancer survivors is related to pretreatment reproductive desire,
age, and parenthood status. The desire for children persisted
among those who were younger and often childless, which is
in line with earlier studies showing that survivors’ desire to
have children remains persistent through the cancer treatment
[18, 23, 32]. In contrast, older survivors, who to a larger extent
had fulfilled their reproductive desire, no longer reported
wanting children 3 to 7 years after diagnosis. Our study did
not investigate the reasons for no longer wanting children, but
earlier research has reported that additional explanations for
why survivors change their mind to not want children could
include fear of cancer recurrence and of transmitting the
cancer risk to offspring [18, 23, 32].
One out of six of the participants who reported having no
pretreatment desire to have children had changed their mind
about wanting children several years after diagnosis. Those
who reported a definite desire for children at the time of study
were characterized by their young age and by having no
children. Since pretreatment desire to have children has been
reported to have a significant influence on the probability of
receiving fertility-related treatment information [7], young
adult cancer patients with no firm desire for children at the
start of treatment may be at risk of not receiving adequate
information about the impact of treatment on future reproduc-
tive ability and information about FP options. While it is
essential to respect each patient’s standpoint regarding future
Table 3 Infertility distress among female and male survivors with present difficulties achieving a pregnancy
Variables Women (n=7) Men (n=12) Possible range
Fertility Problem Inventory (FPI)a, mean (SD)
Global stress 178.2 (43.2) 125.6 (24.3) 46–276
FPI-dimension RIP 76.7 (18.4) 64.7 (9.3) 18–108
Rejection of childfree lifestyle 32.8 (7.9) 27.9 (3.9) 8–48
Need for parenthood 43.8 (10.6) 38.1 (8.2) 10–60
FPI-dimension ILD 95.6 (28.9) 60.9 (18.4) 28–168
Sexual concern 25.1 (10.7) 18.7 (6.2) 8–48
Social concern 33.6 (8.3) 21.6 (8.2) 10–60
Relationship concern 31.5 (13.9) 22.1 (9.2) 10–60
RIP representations about the importance of parenthood, ILD impact on life domains
a High values indicated high level of infertility-related distress
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children, these findings stress the importance to also discuss
fertility-related aspects of treatment and FPwith those patients
who have no expressed desire for children, particularly those
of young age and with no previous children. This is also
supported in a previous research showing that firm plans
regarding future children do not fully predict the desire to
pursue fertility preservation [33].
Among survivors with a pretreatment desire for children,
those with an unfulfilled desire reported lower mental health
scores compared to those who had succeeded in having chil-
dren after the treatment. This is in line with findings by
Canada and Schover [18] indicating that women who had
not been able to conceive after cancer treatment had more
intrusive thoughts, used more avoidance strategies, and re-
ported a higher level of emotional distress about infertility
than women who had had children. In the present study, the
poorer outcomes in mental health among those with an unful-
filled desire for children compared with those who had been
able to have children may not be exclusively attributable to
infertility distress, and other factors may be involved
explaining the outcome, for example, worse physical health
affecting the mental health.
In the present study, about a third of the survivors with a
desire to have children had experienced difficulties con-
ceiving after the cancer treatment. This can be compared
with the worldwide prevalence of infertility at approxi-
mately 15 % [34]. The level of infertility distress among
female and male survivors with present difficulties achiev-
ing a pregnancy was in line with values reported for 525
couples referred for infertility treatment [35], supporting
recent findings of no differences in mental health between
infertile women with and without cancer experience [36].
According to our results, both men and women reported a
fairly low likelihood of using gamete donation in case of
infertility, but women were slightly more positive towards
using donated eggs than men were towards using donated
sperm. An earlier research has been inconclusive
concerning attitudes towards using gamete donation
among men and women in the general population [37].
The present study is based on a large population-based
sample including female and male cancer survivors, and the
results are judged to be representative for men and women
diagnosed in reproductive age receiving treatment with a
possible negative impact on fertility. While the relatively
low response rate, particularly among males, is a threat to
external validity, we could not detect any response bias re-
garding age at diagnosis, age at time of study, or time since
diagnosis, and the educational level of study participants was
in parity to the general Swedish population [38]. While wom-
en are commonly found to participate to a higher extent in
survey studies, the difference in response rate could also be
related to a general difference in women’s and men’s valuation
of the studied issues [28, 39]. Whether those who declined
participation had severe health problems to a larger extent than
those who participated is unfortunately not known. However,
it could also be so that those who were better off and had
moved on in life after being treated for cancer chose to not
to participate. The instrument measuring behavioral inten-
tions (VAS) has been used earlier, with satisfactory out-
come [31, 40]. Visual analog scales have been shown to be
valuable tools for assessing different aspects of mood and
well-being [41] and demonstrate high reliability and valid-
ity [41, 42]. Some caution is advised when drawing con-
clusions from self-reported retrospective data, such as the
pretreatment desire for children in the present study. Also,
the results from the subgroup of survivors with current
difficulties achieving a pregnancy should be considered
as tentative as no statistical analyses could be performed
due to low statistical power.
Conclusions
The results of our study indicate that a substantial group of
patients without a desire for children at the time of cancer
treatment may change their mind about wanting children
several years after the treatment. Cancer health-care profes-
sionals need, therefore, to be aware that patients’ plans for
Fig. 1 Famale and male
behavioral intentions in case of
infertility.0 = Entirely Unlikely
and 100 = Higly likely
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future children may change, particularly if the patients are
young and childless at time of diagnosis. An unfulfilled desire
to have children is associated with worse mental health in men
and women diagnosed with cancer in reproductive age. Infor-
mation on potentially negative effects of cancer treatment on
reproduction and on options for fertility preservation should
be provided to all individuals presenting with cancer in repro-
ductive age.
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